发明授权
- 专利标题： EPAC antagonists
-
申请号： US16499050申请日： 2018-03-29
-
公开(公告)号： US11124489B2公开(公告)日： 2021-09-21
- 发明人: Jia Zhou , Zhiqing Liu , Na Ye , Fang Mei , Xiaodong Cheng
- 申请人： Jia Zhou , Zhiqing Liu , Na Ye , Fang Mei , Xiaodong Cheng
- 申请人地址： US TX Galveston; US TX Galveston; US TX Galveston; US TX Galveston; US TX Galveston
- 专利权人： Jia Zhou,Zhiqing Liu,Na Ye,Fang Mei,Xiaodong Cheng
- 当前专利权人： Jia Zhou,Zhiqing Liu,Na Ye,Fang Mei,Xiaodong Cheng
- 当前专利权人地址： US TX Galveston; US TX Galveston; US TX Galveston; US TX Galveston; US TX Galveston
- 国际申请： PCT/US2018/025064 WO 20180329
- 国际公布： WO2018/183626 WO 20181004
- 主分类号： C07D261/08
- IPC分类号： C07D261/08 ; C07D261/20 ; A61P31/04 ; A61P31/12
摘要：
Embodiments are directed to a series of novel EPAC antagonists that are designed, synthesized and evaluated in an effort to develop diversified analogues based on the scaffold of the previously identified high-throughput (HTS) hit ESI-09.
公开/授权文献
- US20200255388A1 EPAC ANTAGONISTS 公开/授权日：2020-08-13